Eloxx Pharmaceuticals, Inc. (ELOX)

USD 0.0

(0.0%)

Long Term Debt Summary of Eloxx Pharmaceuticals, Inc.

  • Eloxx Pharmaceuticals, Inc.'s latest annual long term debt in 2022 was 8.69 Million USD , down -32.09% from previous year.
  • Eloxx Pharmaceuticals, Inc.'s latest quarterly long term debt in 2023 Q3 was 2.62 Million USD , down -21.39% from previous quarter.
  • Eloxx Pharmaceuticals, Inc. reported annual long term debt of 12.8 Million USD in 2021, up 99.72% from previous year.
  • Eloxx Pharmaceuticals, Inc. reported annual long term debt of 6.4 Million USD in 2020, down -41.35% from previous year.
  • Eloxx Pharmaceuticals, Inc. reported quarterly long term debt of 4.03 Million USD for 2023 Q1, down -53.6% from previous quarter.
  • Eloxx Pharmaceuticals, Inc. reported quarterly long term debt of 2.62 Million USD for 2023 Q3, down -21.39% from previous quarter.

Annual Long Term Debt Chart of Eloxx Pharmaceuticals, Inc. (2022 - 1996)

Historical Annual Long Term Debt of Eloxx Pharmaceuticals, Inc. (2022 - 1996)

Year Long Term Debt Long Term Debt Growth
2022 8.69 Million USD -32.09%
2021 12.8 Million USD 99.72%
2020 6.4 Million USD -41.35%
2019 10.92 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD -100.0%
2008 6217.00 USD 10807.02%
2007 57.00 USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%

Peer Long Term Debt Comparison of Eloxx Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD -673.903%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD -572.755%
Biora Therapeutics, Inc. 43.73 Million USD 80.126%
Bio-Path Holdings, Inc. 10 Thousand USD -86820.0%
Better Therapeutics, Inc. 10.34 Million USD 16.003%
Calithera Biosciences, Inc. 136 Thousand USD -6291.176%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD -7125.15%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. 48.87 Million USD 82.217%
Evolutionary Genomics, Inc. 3.74 Million USD -132.174%
Finch Therapeutics Group, Inc. 28.4 Million USD 69.398%
Galera Therapeutics, Inc. 151.04 Million USD 94.246%
Innovation1 Biotech Inc. 218.99 Thousand USD -3868.968%
Kiromic BioPharma, Inc. 911.5 Thousand USD -853.593%
Molecular Templates, Inc. 9.74 Million USD 10.778%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD -364.387%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 54.413%
Panbela Therapeutics, Inc. 4.19 Million USD -107.248%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 91.669%
Statera Biopharma, Inc. 11.43 Million USD 23.962%
TRACON Pharmaceuticals, Inc. 732 Thousand USD -1087.432%
Trevena, Inc. 35.23 Million USD 75.33%
Vaxxinity, Inc. 13.26 Million USD 34.459%
Vaccinex, Inc. 26 Thousand USD -33330.769%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%